Egyptian Group for Pharmaceutical Industries

Egyptian Group for Pharmaceutical Industries (EGPI) is a prominent Egyptian pharmaceutical company specializing in the development, manufacturing, and distribution of branded generic medicines. Founded in 2006 as the manufacturing arm of the Egyptian Group for Drug Trading (EGD), EGPI has established a robust portfolio of over 150 products across diverse therapeutic areas, including cardiovascular, central nervous system, and pediatrics. The company operates state-of-the-art, GMP-certified manufacturing facilities in El Obour City and maintains a strong focus on R&D to drive innovation in the Egyptian and Middle Eastern markets. EGPI exports its high-quality products to more than 15 countries and recently entered a strategic partnership with Abbott to expand its global footprint. The company is currently part of Egypt's national privatization program, with plans for a future public listing.